BD Logo
  • Products
  • Solutions
    • Administrator
      • Ambulatory Surgery Center Solutions
      • Diagnostic Accuracy and Efficiency
      • Hazardous Drug Safety
      • Medication Management Solutions
      • Patient Safety Solutions
      • Sepsis Management
      • Surgical Solutions
      • Targeted Temperature Management
      • Vascular Access Management (VAM)
    • Clinician
      • Ambulatory Surgery Center Solutions
      • Antimicrobial Resistance
      • BD Original Equipment Manufacturing (OEM)
      • Cervical Cancer Screening Portfolio
      • Diagnostic Accuracy and Efficiency
      • Hazardous Drug Safety
      • Medication Management Solutions
      • Patient Safety Solutions
      • Sepsis Management
      • Stone Management
      • Surgical Solutions
      • Targeted Temperature Management
      • Vascular Access Management (VAM)
    • Distributor
      • BD Original Equipment Manufacturing (OEM)
    • Drug Development Company
      • Drug Delivery Systems
    • Medical Device Manufacturer
      • BD Original Equipment Manufacturing (OEM)
    • Laboratory
      • Antimicrobial Resistance
      • BD Original Equipment Manufacturing (OEM)
      • Cervical Cancer Screening Portfolio
      • Diagnostic Accuracy and Efficiency
      • Patient Safety Solutions
      • Sepsis Management
      • Traditional Microbiology
    • Pharmacy
      • Hazardous Drug Safety
      • Patient Safety Solutions
      • Medication Management Solutions
      • Sepsis Management
      • Vascular Access Management (VAM)
    • Surgery
      • Ambulatory Surgery Center Solutions
      • Hernia Repair Solutions
      • Patient Safety Solutions
      • Surgical Solutions
      • Venous technology
  • Knowledge Center
    • Events
    • Literature
    • Training
  • Support
  • About BD
    • Our Company
      • About Us
      • Segments
      • Leadership
      • Ethics and Compliance
    • Cybersecurity at BD
      • About Us
      • Trust Center
      • Bulletins and Patches
      • Disclosure Process
      • Helpful Resources
    • Distributors
      • Distributor List
      • Unique device identifier (UDI)
    • ESG (Environmental, Social, and Governance)
      • Global Health
      • Sustainability
      • Social Investing
      • Inclusion, Diversity & Equity
    • Global External Funding Opportunities
    • Investors
    • Innovation at BD
      • Overview
      • BD Idea Submission Process
    • News, Media and Blogs
    • Policies, Guidelines and Statements Center
    • Quality
    • Recent Mergers and Acquisitions
    • Response to COVID-19
      • Rapid COVID-19 Testing
      • Tools and Trainings
      • Support Offerings
    • Suppliers
      • Corporate Policies and Expectations
      • Doing Business with BD
      • Global Procurement
      • Supplier Programs
  • Careers
  • Country

    United States

    • North America
      • Canada (FR)
      • Canada (EN)
      • Mexico
      • United States
    • South America
      • Argentina
      • Brasil
      • Chile
      • Colombia
    • Europe
      • Belgium (FR)
      • Belgium (NL)
      • Česká republika
      • Denmark
      • Europe
      • Suomi
      • France
      • Deutschland
      • Hebrew
      • Hungary (EN)
      • Hungary (HU)
      • United Kingdom
      • Ireland
      • Italia
      • Nederland
      • Norge
      • Polska
      • Россия
      • España
      • Sverige
      • Schweiz
      • Türkiye
      • United Kingdom
    • Middle East / Africa
      • Middle East, North Africa
      • Africa
    • Asia / Pacific
      • Australia / New Zealand
      • 中国
      • Greater Asia
      • India
      • Indonesia
      • 日本
      • Korea
      • Malaysia
      • Philippines
      • Singapore
      • Thailand
      • Vietnam
  • Login

    Login

  • Country

    United States

    North America
    • Canada (FR)
    • Canada (EN)
    • Mexico
    • United States
    South America
    • Argentina
    • Brasil
    • Chile
    • Colombia
    Europe
    • Belgium (FR)
    • Belgium (NL)
    • Česká republika
    • Denmark
    • Europe
    • Suomi
    • France
    • Deutschland
    • Hebrew
    • Hungary (EN)
    • Hungary (HU)
    • United Kingdom
    • Ireland
    • Italia
    • Nederland
    • Norge
    • Polska
    • Россия
    • España
    • Sverige
    • Schweiz
    • Türkiye
    • United Kingdom
    Middle East / Africa
    • Middle East, North Africa
    • Africa
    Asia / Pacific
    • Australia / New Zealand
    • 中国
    • Greater Asia
    • India
    • Indonesia
    • 日本
    • Korea
    • Malaysia
    • Philippines
    • Singapore
    • Thailand
    • Vietnam
  • Login

    Login

Products

BD Cathena™ Safety IV Catheter with BD Multiguard™ Technology 

Connect to confidence, care and comfort

Contact Us
Background Image
Loading
  1. Overview
  2. Products & Accessories
  3. EIFU & Resources
  4. FAQ
Overview

BD Cathena™ Safety IV Catheter with BD Multiguard™ Technology elevates the level of safety by combining needlestick safety with blood control technology compared to a non-safety, non-blood control catheter.

 

When clinician safety and improved patient care and comfort are critical, trust BD Cathena™ Safety IV Catheter with BD Multiguard™ Technology:

  • Incorporates a notched needle, BD Instaflash™ Needle Technology, which clinically demonstrated improved first-attempt insertion success, reducing painful hit-and-miss insertions.
  • Provides protection from needlestick injury and associated risk by automatically shielding the needle
  • Designed to stop blood leakage^**
  • Enables longer dwell times with reduced chance of mechanical phlebitis by up to 50% with BD Vialon™ Catheter Material†
true

IV placement is the most common invasive hospital procedure worldwide.1

Approximately 90% of hospital patients receive IV therapy.1 Globally, 1 billion+ peripheral IV catheters are placed every year.2   

95% of IV catheters placed are PIVCs.1 Based on clinical studies, risks associated with PIVC use include:

35% - 50% of patients received a PIV catheter complication

Potentially high frequency of PIV catheter complications 

35–50% of hospitalized patients who receive a PIVC experience a catheter-related complication.3

Drug library updates

Occurance of blood exposure 

In a study, when clinicians used a PIVC without blood control technology, blood leakage occurred 61% of the time,4 risking potential exposure to bloodborne pathogens (BBP).

Multiple PIVC insertion attempts

An emergency department study suggests that first attempt insertion success ranges from 18–79%.6

Multiple insertion attempts increase the risk to clinicians of needlestick injury (NSI) and potential exposure to BBP, and undue pain and increased infection risk to the patient.6

Features and Benefits 

When clinician safety and patient comfort and care are critical, BD Cathena™ Safety IV Catheter with BD Multiguard™ Technology**:

  • Eliminates the need for venous compression

    during insertion, connections and disconnections, and blood draws, reducing the risk of blood exposure.**,7

     

     

  • Reduces blood exposure risk**

    by stopping blood flow during conections and reconnections.^,7

     

  • Provides immediate visual confirmation

    of vessel entry with BD Instaflash™ Needle Technology, improving opportunities for first attempt insertion success.*,8,9

     

     

  • Provides protection from needlestick injuries (NSIs)

    with integrated passive safety system.

  • Offers an ergonomic design 

    that is easily adaptable to preferred insertion techniqes and provides enhanced control throughout the procedure.

  • Clinically demonstrated to reduce phlebitis

    by up to 69% with BD Vialon™ Catheter Material, compared to an FEP catheter material.10-12

  • Supports longer IV dwell times,

    with BD Vialon™ Catheter Material.††,13

  • Smooth, tapered catheter tip design

     

    with smooth, tapered catheter tip design.**

BD Cathena™ Safety IV Catheter with BD Multiguard™ Technology

The BD Cathena™ Safety IV Catheter with BD Multiguard™ Technology is designed to enhance the confidence, care and comfort of clinicians and patients.

Products & Accessories
RELATED PRODUCTS NOT AVAILABLE
References
false
Resources
events.svg
Literature

BD's collection of literature on industry and on our offerings gives you information you can use to continue striving for excellence.

Learn more
EIFUs

  • BD products
  • Select Vascular Access Device products
  • Surgical Instruments and Sterilization Container products
true
Frequently Asked Questions

BD Cathena™ Safety IV Catheter with BD Multiguard™ Technology FAQs

Yes. BD Cathena™ Safety IV Catheter is MR Conditional. Please refer to the Instructions for Use for the specified conditions for use.

Yes. BD Cathena™ Safety IV Catheter are acceptable for use with power injectors up to 325 psi (2,240 kPa).

Yes. BD Cathena™ Safety IV Catheters are available with and without wings.

BD Cathena™ Safety Peripheral IV Catheter (PIVC) with BD Multiguard™ Technology is a multi-use blood control catheter that does not require venous compression during insertion and subsequent luer connection and disconnection.^

BD Cathena™ Safety IV Catheters feature BD Vialon™ Catheter Material. BD Vialon™ is a polyurethane material that has been clinically demonstrated to reduce phlebitis up to 69% compared to an FEP catheter material.10,11,12,*

BD Cathena™ Safety IV Catheter features BD Instaflash™ Needle Technology designed to provide immediate visual confirmation of vessel entry (flashback) and was clinically demonstrated to improve first-attempt insertion success, reducing painful hit-and-miss insertions.8,9,*

No. BD Cathena™ Safety IV Catheter has a passive needle shield that automatically covers the needle as it is removed from the catheter, protecting against needlestick injuries and exposure to blood.

Yes. BD Cathena™ Safety IV Catheter can be used to draw blood. BD Cathena™ Catheters are intended to be inserted into a patient's peripheral vascular system for short-term use to sample blood, monitor blood pressure, or administer fluids.

Yes. The BD Cathena™ Safety IV Catheter is ergonomically designed to be easily adaptable to current insertion techniques, while the anti-rotation tab is designed to enhance tactile control during advancement.

true
Reference

Disclaimers:

*Compared to a non-notched needle
†
Compared to an FEP catheter
^
For up to 10 seconds
**
Compared to a non-safety, non-blood control catheter
††Compared to PTFE catheter material

  1. iData Research Inc. Global Market Report Suite for Vascular Access Devices and Accessories. 2020.
  2. Alexandrou E, Ray-Barruel G, Carr PJ, et al. International prevalence of the use of peripheral intravenous catheters. Journal of Hospital Medicine. 2015 Aug 1;10(8):530-533.
  3. Helm RE, Klausner JD, Klemperer JD, et al. Accepted but unacceptable: peripheral IV catheter failure. J Infus Nurse. 2015;38(3):189-203.
  4. Haeseler G, Hildebrand M, Fritscher J. Efficacy and ease of use of an intravenous catheter designed to prevent blood leakage: prospective observational study. J Vasc Access. 2015;16(3):233-236.
  5. Rickard C, Webster J, Wallis MC, et al. Routine versus clinically indicated replacement of peripheral intravenous catheters: a randomised controlled equivalence trial. Lancet [serial online]. 2012;380:1066-1074.
  6. Carr P, Rippey J, Budgeon C, Cooke M, Higgins N, Rickard C. Insertion of peripheral intravenous cannulae in the Emergency Department: factors associated with first-time insertion success. J Vasc Access. 2016;17(2):182-190.
  7. Onia R, Eshu-Wilson I, Arce, C, et al. Evaluation of a new safety peripheral IV catheter designed to reduce mucocutaneous blood exposure. CMRO. 2011;27(7):1339-1346. 8 Maki DG, Ringer M. Risk factors for infusionrelated phlebitis with small peripheral venous catheters. Annals of Internal Medicine. 1991;114:845-854.
  8. van Loon FHJ, Timmerman R, den Brok GPH, Korsten EHM, Dierick-van Daele ATM, Bouwman ARA. The impact of a notched peripheral intravenous catheter on the first attempt success rate in hospitalized adults: block-randomized trial. JVA. 2021 DOI: 10.1177/1129729821990217.
  9. Seetharam AM, Raju U, Suresh K. A randomized controlled study to compare first stick success with Instaflash technology: The FIRSST study. JVA. 2022 DOI:10.1177/11297298221080369.
  10. Kus B, Buyukyilmaz F. Effectiveness of Vialon biomaterial versus Teflon catheters for peripheral intravenous placement: A randomized clinical trial. Jpn J Nurs Sci. 2020;e12328. https://doi.org/10.1111/jjns.12328
  11. Maki DG, Ringer M. Risk factors for infusion-related phlebitis with small peripheral venous catheters. Annals of Internal Medicine. 1991;114:845-854.
  12. Gaukroger PB, Roberts JG, Manners TA. Infusion thrombophlebitis: a prospective comparison of 645 Vialon and Teflon cannulae in anaesthetic and postoperative use. Anaesthesia and Intensive Care. 1988;16:265-271.
  13. Chhugani M, James M, Thokchom S. A randomized controlled trial to assess the effectiveness of Vialon™ cannula versus polytetrafluoroethylene (PTFE) cannula in terms of indwelling time and complications in patients requiring peripheral intravenous cannulation. International Journal of Science and Research. 2015;4(12).
  14. Richardson D, Kaufman L. Reducing blood exposure risks and costs associated with SPIVC insertion. Nurse Manage. 2011;42(12):31-34.

 

BD-42420 (05/23)

  • Follow us
    • Linked In
    • Facebook
    • Instagram
    • Twitter
    • Youtube
Quick Links
  • Recalls and Field Actions
  • Careers
  • Cybersecurity
  • Electronic Instructions for Use
  • Events
  • Investors
  • Inclusion, Diversity & Equity
  • Literature
  • Live Chat Support
  • News, Media and Blogs
  • Our Company
  • Ethics and Compliance
  • Support
  • Training
BD_tag_en_1-Color_Reverse_RGB_TransparentBurst

© 2023 BD. All rights reserved. BD and the BD Logo are trademarks of Becton, Dickinson and Company. All other trademarks are the property of their respective owners.

  • Contact us
  • Cookie Preferences
  • Privacy
  • Terms of Use
  • Website Accessibility
  • Your Privacy Rights
  • Limit the use of Sensitive Personal Information
Chat with us
Our live chat is available between the hours of 8.30am - 5.00pm EST, Monday - Friday
×